This study reveals that Dl-3-n-butylphthalide (NBP) improves learning deficits and reduces Aβ plaque deposition in Alzheimer's disease (AD) transgenic mice by enhancing microglial activation and phagocytosis of Aβ plaques. The therapeutic effects of NBP are linked to the AGE-RAGE signaling pathway, demonstrating its potential in alleviating cognitive impairment and neuroinflammation in AD.
This Article supports SDG3 by evaluating sex and gender disparities in terms of risk factors, treatment uptake/completion, and virological outcomes for hepatitis C, finding differences between men and women in, for example, exposure to different risk factors and likelihood of commencing treatment. More attention is needed in research to these disparities and how they could be addressed
Elsevier,

Canadian Journal of Cardiology, Volume 40, June 2024

This review article summarizes the current evidence for culturally adapted cardiac rehabilitation programming for Indigenous patients, including community engagement. strategies to improve education on cardiovascular risk-factor optimization and to promote guideline-based exercise and diet programs through an Indigenous perspective.

This study, led by Indigenous scholars at the University of Queensland, examines the health and social outcomes of Indigenous peoples and health workers during pandemics in urban settings. The study incorporates systems thinking, emphasising new approaches to complex problems. The research highlighted systemic challenges in pandemic responses, emphasising the need for policy reform, particularly in areas like housing.

This chapter advances the UN SDG goals 3 and 9 by exploring the potential benefits and ethical considerations of AI tools in healthcare settings.

This content aligns with Goal 3: Good Health provides understanding the mechanisms involved in AIH pathogenesis controlling hepatitic inflammation.

The findings contribute to a deeper understanding of the unique social and emotional wellbeing needs of Aboriginal and Torres Strait Islander peoples accessing home-based aged care services and have significant implications for current and future aged care reforms in Australia.

The study introduces a nano-modulator that targets the damaged blood-brain barrier in Alzheimer’s disease. This modulator releases therapeutic agents that reduce amyloid-beta load, alleviate neuroinflammation, and restore neurovascular unit function, showing potential for Alzheimer’s treatment.

Elsevier,

Bioreactor Design Concepts for Viral Vaccine Production: Progress in Biochemistry and Biotechnology, 2024, Pages 297-310

This content aligns with Goal 3: Good Health The chapter provides information on a cost-effective and easy way to produce the vaccine grade HCV.

This study aimed to assess the correlation between antidiabetic agents and platelet characteristics, hoping to provide a potential mechanism of TZDs neuroprotection in AD

Pages